Gonorrhea Surveillance: Estimating Epidemiologic and Clinical Characteristics of Reported Cases Using a Sample Survey Methodology

Sexually Transmitted Diseases

Volumn 31, Issue 4, 2004, Pages 215-220

  Mark, Karen E ^a,b,d   Gunn, Robert A ^b,c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b S Diego Co Hlth/Hum Serv Agy   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE TRANSMISSION; DNA PROBE; FEMALE; GONORRHEA; HEALTH SURVEY; HOMOSEXUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEISSERIA GONORRHOEAE; NUCLEIC ACID AMPLIFICATION; PATIENT REFERRAL; RISK FACTOR; SCREENING TEST; SEXUAL BEHAVIOR; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; SYMPTOMATOLOGY; TREATMENT PLANNING; UNITED STATES;

EID: 1642463883     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.OLQ.0000118421.15177.34     Document Type: Article

References (19)

1. California Department of Health Services, Sexually Transmitted Disease Control Branch, Gonorrhea. 1997-2001 Provisional Tables. Available at: http://www.dhs.ca.gov/ps/dcdc/std/datatables.htm. Accessed May 1, 2003.
2. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2001. Atlanta: US Department of Health and Human Services, September 2002.
3. Centers for Disease Control and Prevention. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae-Hawaii and California, 2001. Morb Mortal Wkly Rep 2002; 51:1041-1044.
4. Gregg MB, ed. Field Epidemiology. New York: Oxford University Press, 1996:104.
5. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997; 337:1105-1111.
6. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341:556-562.
7. Francis DP, Hadler SC, Prendergast TJ, et al. Occurrence of hepatitis A, B, and non-A/non-B in the United States. CDC sentinel county hepatitis study I. Am J Med 1984; 76:69-74.
8. Turner CF, Rogers SM, Miller HG, et al. Untreated gonococcal and chlamydial infection in a probability sample of Baltimore adults. JAMA 2002; 287:726-733.
9. Rogers SM, Miller HG, Miller WC, Zenilman JM, Turner CF. NAAT-identified and self-reported gonorrhea and chlamydial infections: Different at-risk population subgroups? Sex Transm Dis 2002; 29:588-596.
10. Ruiz JD, Molitor F, McFarland W, et al. Prevalence of HIV infection, sexually transmitted diseases, and hepatitis and related risk behavior in young women living in low-income neighborhoods of northern California. West J Med 2000; 172:368-373.
11. Ellen JM, Kohn RP, Bolan GA, Shiboski S, Krieger N. Socioeconomic differences in sexually transmitted disease rates among black and white adolescents, San Francisco, 1990 to 1992. Am J Public Health 1995; 85:1546-1548.
12. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2001 supplement: Gonococcal Isolate Surveillance Project (GISP) Annual Report-2001. Atlanta: US Department of Health and Human Services, 2002.
13. Fox KK, del Rio C, Holmes KK, et al. Gonorrhea in the HIV era: A reversal in trends among men who have sex with men. Am J Public Health 2001; 91:959-964.
14. St. Lawrence JS, Montaño DE, Kasprzyk D, Phillips WR, Armstrong K, Leichliter JS. STD screening, testing, case reporting, and clinical and partner notification practices: A national survey of US physicians. Am J Public Health 2002; 92:1784-1788.
15. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. Morb Mortal Wkly Rep 2002; 51(No. RR-6): 2,8,36.
16. Centers for Disease Control and Prevention. Discontinuation of cefixime tablets-United States. Morb Mortal Wkly Rep 2002; 51:1052.
17. Gunn RA, Rolfs RT, Greenspan JR, Seidman RL, Wasserheit JN. The changing paradigm of sexually transmitted disease control in the era of managed health care. JAMA 1998; 279:680-684.
18. Montaño DE, Phillips WR. Cancer screening by primary care physicians: A comparison of rates obtained from physician self-report, patient survey, and chart audit. Am J Public Health. 1995; 85:795-800.
19. Weinberg MS, Gunn RA, Mast EE, Gresham L, Ginsberg M. Preventing transmission of hepatitis B virus from people with chronic infection. Am J Prev Med 2001; 20:272-276.